EUROFINS SCIENT Debt Issuance/Retirement Net - Total 2018-2025 | ERFSF
EUROFINS SCIENT annual/quarterly debt issuance/retirement net - total history and growth rate from 2018 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
- EUROFINS SCIENT debt issuance/retirement net - total for the quarter ending June 30, 2025 was $-0.389B, a 27.49% decline year-over-year.
- EUROFINS SCIENT debt issuance/retirement net - total for the twelve months ending June 30, 2025 was $-0.346B, a 81.99% decline year-over-year.
- EUROFINS SCIENT annual debt issuance/retirement net - total for 2024 was $-0.597B, a 250% decline from 2023.
- EUROFINS SCIENT annual debt issuance/retirement net - total for 2023 was $0.398B, a 1.79% decline from 2022.
- EUROFINS SCIENT annual debt issuance/retirement net - total for 2022 was $0.406B, a 156.46% decline from 2021.
| EUROFINS SCIENT Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2024 | $-597 |
| 2023 | $398 |
| 2022 | $406 |
| 2021 | $-718 |
| 2020 | $-581 |
| 2019 | $-168 |
| 2018 | $971 |
| 2017 | $837 |
| 2016 | $N/A |
| 2015 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.474B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.686B | 27.39 |
| CVS Health (CVS) | United States | $90.749B | 11.28 |
| Elevance Health (ELV) | United States | $69.812B | 9.39 |
| Cencora (COR) | United States | $56.166B | 18.70 |
| DiDi Global (DIDIY) | China | $27.862B | 29.60 |
| Labcorp Holdings (LH) | United States | $23.139B | 18.39 |
| Natera (NTRA) | United States | $22.743B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| ICON (ICLR) | Ireland | $13.871B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.184B | 34.89 |
| CochLear (CHEOY) | Australia | $12.924B | 0.00 |
| Solventum (SOLV) | United States | $12.643B | 13.05 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 18.66 |
| Avantor (AVTR) | United States | $9.067B | 13.30 |
| Charles River Laboratories (CRL) | United States | $8.057B | 15.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.112B | 34.38 |
| Sotera Health (SHC) | United States | $4.658B | 26.03 |
| BrightSpring Health Services (BTSG) | United States | $4.246B | 32.39 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.627B | 83.06 |
| Alignment Healthcare (ALHC) | United States | $3.105B | 0.00 |
| KindlyMD (NAKA) | United States | $3.035B | 0.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.358B | 2.57 |
| Premier (PINC) | United States | $2.129B | 19.74 |
| Progyny (PGNY) | United States | $1.947B | 41.16 |
| Ardent Health (ARDT) | United States | $1.793B | 6.92 |
| PACS (PACS) | United States | $1.777B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.504B | 25.47 |
| Pediatrix Medical (MD) | United States | $1.483B | 9.90 |
| Teladoc Health (TDOC) | United States | $1.380B | 0.00 |
| Omada Health (OMDA) | $1.246B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.210B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.831B | 4.87 |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 9.64 |
| CareDx (CDNA) | United States | $0.682B | 12.56 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Nutex Health (NUTX) | United States | $0.500B | 7.57 |
| Sonida Senior Living (SNDA) | United States | $0.495B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.493B | 84.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.457B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.455B | 6.83 |
| So-Young (SY) | China | $0.433B | 0.00 |
| SBC Medicals (SBC) | United States | $0.426B | 9.32 |
| Enhabit (EHAB) | United States | $0.402B | 26.47 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.227B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.149B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |